William Blair Predicts Reduced Earnings for DENTSPLY SIRONA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Stock analysts at William Blair cut their FY2024 earnings estimates for shares of DENTSPLY SIRONA in a research note issued to investors on Thursday, November 7th. William Blair analyst B. Vazquez now expects that the medical instruments supplier will post earnings per share of $1.84 for the year, down from their prior estimate of $1.98. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. William Blair also issued estimates for DENTSPLY SIRONA's Q1 2025 earnings at $0.41 EPS, Q2 2025 earnings at $0.52 EPS, Q3 2025 earnings at $0.53 EPS, Q4 2025 earnings at $0.50 EPS, Q2 2026 earnings at $0.58 EPS and Q3 2026 earnings at $0.58 EPS.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. The business had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company's revenue was up .4% on a year-over-year basis. During the same quarter last year, the business posted $0.49 EPS.

Other analysts have also issued reports about the stock. Needham & Company LLC cut their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating on the stock in a research note on Friday, October 25th. Robert W. Baird decreased their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating for the company in a research report on Friday. StockNews.com raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Wednesday, November 6th. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a research note on Thursday. Finally, Evercore ISI reduced their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a research note on Tuesday, October 8th. Six investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of "Hold" and an average price target of $29.50.

DENTSPLY SIRONA Trading Down 1.2 %

Shares of XRAY traded down $0.21 during midday trading on Monday, reaching $17.65. The company had a trading volume of 5,276,088 shares, compared to its average volume of 3,125,136. The company has a quick ratio of 0.87, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The firm has a 50 day simple moving average of $24.52 and a 200-day simple moving average of $25.74. DENTSPLY SIRONA has a 1-year low of $17.21 and a 1-year high of $37.60. The stock has a market cap of $3.58 billion, a PE ratio of -8.53, a price-to-earnings-growth ratio of 0.97 and a beta of 1.02.

Institutional Trading of DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently made changes to their positions in XRAY. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in DENTSPLY SIRONA by 44.2% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 141,117 shares of the medical instruments supplier's stock valued at $4,684,000 after buying an additional 43,230 shares in the last quarter. Scientech Research LLC bought a new position in DENTSPLY SIRONA in the 2nd quarter valued at $846,000. Seven Eight Capital LP bought a new stake in DENTSPLY SIRONA during the 1st quarter worth about $1,409,000. Intech Investment Management LLC bought a new position in DENTSPLY SIRONA in the 1st quarter worth approximately $1,202,000. Finally, Lazard Asset Management LLC boosted its holdings in DENTSPLY SIRONA by 3.2% in the first quarter. Lazard Asset Management LLC now owns 4,080,795 shares of the medical instruments supplier's stock valued at $135,440,000 after acquiring an additional 126,351 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.